LISDEXAMFETAMINE 20 MG TB CHEW

lisdexamfetamine dimesylate
$4.3059per EA
DEA Schedule CII

Strength

20 mg/1

NDC

00480973801

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215415

On Market Since

9/16/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-5.4%

3M

-23.6%

6M

-31.3%

1Y

-48.5%

3Y

N/A

5Y

N/A

All

-48.2%